Dr. Allegra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Sw Archer Rd
Gainesville, FL 32610Phone+1 352-265-0111Fax+1 352-273-6867
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1986 - 1987
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1979 - 1982
- Perelman School of Medicine at the University of PennsylvaniaClass of 1979
Certifications & Licensure
- FL State Medical License 2007 - 2025
- PA State Medical License 1981 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 1991
Clinical Trials
- Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer Start of enrollment: 2004 Sep 15
- NSABP Biospecimen Discovery Project Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR.Song Han, Gerik W Tushoski-Alemán, Peiyi Zhang, Guangrong Zheng, Daohong Zhou
Neoplasia. 2025-01-01 - Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.Thomas J George, Ji-Hyun Lee, David L DeRemer, Peter J Hosein, Steven Staal
JCO Precision Oncology. 2024-12-01 - Phase III Evaluation of Treatment Combinations in Three-Arm Trials.Edward L Korn, Carmen J Allegra, Boris Freidlin
Journal of Clinical Oncology. 2024-10-28
Press Mentions
- Tucatinib and Trastuzumab Combination Approved for Advanced Colorectal CancerFebruary 10th, 2023
- Nivolumab Improves Survival for Some Patients with Advanced Stomach CancerOctober 20th, 2020
- Liraglutide Gets FDA Indication for Reducing CVD Risk, but Not so FastJune 24th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: